Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC

NCT04912128 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Stereotactic Body Radiation Therapy

Interventions

DRUG: Anlotinib

Sponsor

Peking University Third Hospital

Collaborators

[object Object]
[object Object]